Product Information
MORPHINE SULFATE ER 10 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $2.6345 per EA under NDC 00832022500. Its NADAC has been published 632 times since May 21, 2014.
Strength
10 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832022500
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA202104On Market Since
6/30/2013
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 10 MG CAP has been published 632 times since May 21, 2014, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6345 per EA |
|---|---|
| All-time high | $3.1462 (Dec 12, 2018) |
| All-time low | $1.2094 (May 19, 2021) |
| 52-week high | $2.9247 |
| 52-week low | $2.5427 |
| Median price | $2.6117 |
| Average price | $2.5847 |
| Largest weekly change | +85.5% (Jun 23, 2021) |
| Weeks tracked | 632 |
| Tracking since | May 21, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Morphine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 10 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 10 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $2.6345 per EA (NDC 00832022500), effective Jun 24, 2026.
How has the price of MORPHINE SULFATE ER 10 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 10 MG CAP has declined 9.4%. It has been tracked across 632 weekly CMS publications since May 21, 2014.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 10 MG CAP?
Since May 21, 2014, the NADAC for MORPHINE SULFATE ER 10 MG CAP has ranged from a low of $1.2094 (May 19, 2021) to a high of $3.1462 (Dec 12, 2018), with a median of $2.6117 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 10 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MORPHINE SULFATE ER 10 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 10 MG CAP?
MORPHINE SULFATE ER 10 MG CAP (NDC 00832022500) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification